| Cytochrome P450: taming a wild type enzyme ST Jung, R Lauchli, FH Arnold Current opinion in biotechnology 22 (6), 809-817, 2011 | 343 | 2011 |
| High-resolution antibody dynamics of vaccine-induced immune responses U Laserson, F Vigneault, D Gadala-Maria, G Yaari, M Uduman, ... Proceedings of the National Academy of Sciences 111 (13), 4928-4933, 2014 | 201 | 2014 |
| Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells ST Jung, ST Reddy, TH Kang, MJ Borrok, I Sandlie, PW Tucker, ... Proceedings of the National Academy of Sciences 107 (2), 604-609, 2010 | 174 | 2010 |
| Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response Y Wine, DR Boutz, JJ Lavinder, AE Miklos, RA Hughes, KH Hoi, ST Jung, ... Proceedings of the National Academy of Sciences 110 (8), 2993-2998, 2013 | 164 | 2013 |
| Revisiting the role of glycosylation in the structure of human IgG Fc MJ Borrok, ST Jung, TH Kang, AF Monzingo, G Georgiou ACS chemical biology 7 (9), 1596-1602, 2012 | 163 | 2012 |
| Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy ST Jung, TH Kang, W Kelton, G Georgiou Current opinion in biotechnology 22 (6), 858-867, 2011 | 135 | 2011 |
| Boosting therapeutic potency of antibodies by taming Fc domain functions TH Kang, ST Jung Experimental & molecular medicine 51 (11), 1-9, 2019 | 118 | 2019 |
| Engineering therapeutic antibodies targeting G-protein–coupled receptors M Jo, ST Jung Experimental & molecular medicine 48 (2), e207-e207, 2016 | 115 | 2016 |
| Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity ST Jung, W Kelton, TH Kang, DTW Ng, JT Andersen, I Sandlie, CA Sarkar, ... ACS chemical biology 8 (2), 368-375, 2013 | 82 | 2013 |
| Expression and purification of enzymatically active forms of the human lysyl oxidase-like protein 4 MS Kim, SS Kim, ST Jung, JY Park, HW Yoo, J Ko, K Csiszar, SY Choi, ... Journal of biological chemistry 278 (52), 52071-52074, 2003 | 80 | 2003 |
| Purification of enzymatically active human lysyl oxidase and lysyl oxidase-like protein from Escherichia coli inclusion bodies ST Jung, MS Kim, JY Seo, HC Kim, Y Kim Protein expression and purification 31 (2), 240-246, 2003 | 72 | 2003 |
| Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics MS Ju, ST Jung Current opinion in biotechnology 30, 128-139, 2014 | 63 | 2014 |
| The highly evolvable antibody Fc domain HI Park, HW Yoon, ST Jung Trends in biotechnology 34 (11), 895-908, 2016 | 52 | 2016 |
| Structure-guided directed evolution of highly selective p450-based magnetic resonance imaging sensors for dopamine and serotonin EM Brustad, VS Lelyveld, CD Snow, N Crook, ST Jung, FM Martinez, ... Journal of molecular biology 422 (2), 245-262, 2012 | 46 | 2012 |
| Binding and enrichment of Escherichia coli spheroplasts expressing inner membrane tethered scFv antibodies on surface immobilized antigens ST Jung, KJ Jeong, BL Iverson, G Georgiou Biotechnology and bioengineering 98 (1), 39-47, 2007 | 38 | 2007 |
| Recent achievements and challenges in prolonging the serum half-lives of therapeutic IgG antibodies through Fc engineering S Ko, M Jo, ST Jung BioDrugs 35 (2), 147-157, 2021 | 30 | 2021 |
| Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance M Jo, HS Kwon, KH Lee, JC Lee, ST Jung MAbs 10 (2), 278-289, 2018 | 29 | 2018 |
| Immunoglobulin Fc polypeptides G Georgiou, ST Jung, S Reddy US Patent 8,679,493, 2014 | 29 | 2014 |
| Immunoglobulin Fc libraries G Georgiou, ST Jung US Patent 8,629,245, 2014 | 28 | 2014 |
| Recent development of highly sensitive protease assay methods: Signal amplification through enzyme cascades HK Yoon, ST Jung, JH Kim, TH Yoo Biotechnology and bioprocess engineering 17, 1113-1119, 2012 | 22 | 2012 |
George GeorgiouUniversity of Texas at AustinGeverifieerd e-mailadres voor che.utexas.edu
